Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Leukemia Research
|
July 21, 1998
Suppression of Wilms' tumor gene (WT1) expression induces G2/M arrest in leukemic cells
T Yamagami, H Ogawa, H Tamaki, et al.
Pharmacology & Therapeutics
|
January 1, 1992
Activation of lymphokine genes in T cells: role of cis-acting DNA elements that respond to T cell activation signals
N Arai, Y Naito, M Watanabe, et al.
Leukemia
|
May 26, 2007
The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis
N Hosen, T Shirakata, S Nishida, et al.
Leukemia
|
August 27, 2011
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission
Y Hashii, E Sato-Miyashita, R Matsumura, et al.
Japanese Journal of Cancer Research : Gann
|
April 6, 1999
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
Y Oji, H Ogawa, H Tamaki, et al.
The Journal of Biological Chemistry
|
November 25, 1992
The carboxyl terminus of RAP30 is similar in sequence to region 4 of bacterial sigma factors and is required for function
K P Garrett, H Serizawa, J P Hanley, et al.
Leukemia Research
|
June 22, 1999
Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
A Tsuboi, Y Oka, H Ogawa, et al.
Experimental Hematology
|
February 1, 1996
Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP)
L A Potempa, M Motie, K E Wright, et al.
Blood
|
May 16, 1998
Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells
K Inoue, H Tamaki, H Ogawa, et al.
Leukemia
|
December 14, 2011
Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
A Tsuboi, Y Oka, T Kyo, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Leukemia Research
|
July 21, 1998
Suppression of Wilms' tumor gene (WT1) expression induces G2/M arrest in leukemic cells
T Yamagami, H Ogawa, H Tamaki, et al.
Pharmacology & Therapeutics
|
January 1, 1992
Activation of lymphokine genes in T cells: role of cis-acting DNA elements that respond to T cell activation signals
N Arai, Y Naito, M Watanabe, et al.
Leukemia
|
May 26, 2007
The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis
N Hosen, T Shirakata, S Nishida, et al.
Leukemia
|
August 27, 2011
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission
Y Hashii, E Sato-Miyashita, R Matsumura, et al.
Japanese Journal of Cancer Research : Gann
|
April 6, 1999
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
Y Oji, H Ogawa, H Tamaki, et al.
The Journal of Biological Chemistry
|
November 25, 1992
The carboxyl terminus of RAP30 is similar in sequence to region 4 of bacterial sigma factors and is required for function
K P Garrett, H Serizawa, J P Hanley, et al.
Leukemia Research
|
June 22, 1999
Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
A Tsuboi, Y Oka, H Ogawa, et al.
Experimental Hematology
|
February 1, 1996
Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP)
L A Potempa, M Motie, K E Wright, et al.
Blood
|
May 16, 1998
Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells
K Inoue, H Tamaki, H Ogawa, et al.
Leukemia
|
December 14, 2011
Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
A Tsuboi, Y Oka, T Kyo, et al.
Page
of 11